Pharmaceutical supply chain risks: A systematic review

DARU, Journal of Pharmaceutical Sciences

Volumn 21, Issue 1, 2013, Pages

  Jaberidoost, Mona ^a   Nikfar, Shekoufeh ^a   Abdollahiasl, Akbar ^a,b   Dinarvand, Rassoul ^a  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b Dr Abidi Pharmaceuticals   (Iran)

Author keywords

Medicines supply risks; Pharmaceutical risks; Pharmaceutical supply risks; Risks management; Supply chain risks

Indexed keywords

EID: 84893861915     PISSN: 15608115     EISSN: 20082231     Source Type: Journal    
DOI: 10.1186/2008-2231-21-69     Document Type: Review

References (41)

1. Essential medicines and human rights: what can they learn from each other? Hogerzeil HV, B World Health Org 2006 84 371 375 10.2471/BLT.06.031153
2. Supply chain management in the Mexican pharmaceutical industry. Kaufmann L, Thiel C, Becker A, 16th annual North American research/teaching symposium on purchasing and supply chain management Otto Beisheim Graduate School of Management 2005 327 353
3. Pharmaceutical companies and sustainability: an analysis of corporate reporting. Schneider JL, Wilson A, Rosenbeck JM, Benchmarking 2010 17 421 434
4. Examination of risk evaluation and mitigation strategies and drug safety in the US. Rodriguez-Monguio R, Spielberger K, Seoane-Vazquez E, Res Social Adm Pharm 2013 In Press
5. Provision of risk management and risk assessment information: the role of the pharmacist. Schommer JC, Pedersen CA, Worley MM, Brown LM, Hadsall RS, Ranelli PL, Stratton TP, Uden DL, Chewning BA, Res Social Adm Pharm 2006 2 458 478 10.1016/j.sapharm.2006.02.001 17161806 (Pubitemid 44869045)
6. The severity of supply chain disruptions: design characteristics and mitigation capabilities. Craighead CW, Blackhurst J, Rungtusanatham MJ, Handfield RB, Decision Sci 2007 38 131 156 10.1111/j.1540-5915.2007.00151.x
7. Securing the pharmaceutical supply chain. Koh R, Schuster EW, Chackrabarti I, Bellman A, White Paper, Auto-ID Labs, Massachusetts Institute of Technology 2003 1 19
8. An empirical analysis of risk mitigation in the pharmaceutical industry supply chain: a developing-country perspective. Enyinda CI, Mbah CHN, Ogbuehi A, Thunderbird Int Business Revw 2010 52 45 54 10.1002/tie.20309
9. PHP13 Affordability of antibacterial medicines in Iran during 2001-2010. Abdollahiasl A, Jaberidoost M, Farshchi A, Value Health 2012 15 611 A611
10. PHP4 Effectiveness of two policies to reduce Diphenoxylate consumption in Iran. Jaberi Doost M, Abdollahiasl A, Safavi Homami N, Farshchi A, Ghiasi G, Anabi M, Value Health 2010 13 533 A533
11. Impacts of international sanctions on Iranian pharmaceutical market. Cheraghali AM, Daru 2013 21 64 10.1186/2008-2231-21-64 23902642
12. Process industry supply chains: advances and challenges. Shah N, Comput Chem Eng 2005 29 1225 1235 10.1016/j.compchemeng.2005.02.023 (Pubitemid 40630970)
13. The adoption of collaborative practices: a survey on the pharmaceutical supply chain. Secchi R, Veronesi V, 22nd IMP-Conference Milan, Italy: Idustrial Marketing and Purchasing Group 2006
14. Knowledge and information flows in supply chains: a study on pharmaceutical companies. Pedroso MC, Nakano D, Int J Prod Econ 2009 122 376 384 10.1016/j.ijpe.2009.06.012
15. Forces, trends, and decisions in pharmaceutical supply chain management. Rossetti CL, Handfield R, Dooley KJ, Int J Phys Distr Log 2011 41 601 622 10.1108/09600031111147835
16. Pharmaceutical supply chains: key issues and strategies for optimisation. Shah N, Comput Chem Eng 2004 28 929 941 10.1016/j.compchemeng.2003.09.022 (Pubitemid 38520950)
17. Evaluation and modeling of regional drug distribution in Iran. Dinarvand R, Jahanbakhsh H, Teb Va Tazkieh 2001 42 1
18. Wisner JD, Tan K-C, Leong GK, Principles of supply chain management: a balanced approach USA: Thomson South-Western 2011
19. Global supply chain planning for pharmaceuticals. Sousa RT, Liu SS, Papageorgiou LG, Shah N, Chem Eng Res Des 2011 89 2396 2409 10.1016/j.cherd. 2011.04.005
20. Supply chain redesign and new process introduction in multipurpose plants. Naraharisetti PK, Karimi IA, Chem Eng Sci 2010 65 2596 2607 10.1016/j.ces.2009.12.036
21. Demand chain management-integrating marketing and supply chain management. Juttner U, Christopher M, Baker S, Ind Market Manag 2007 36 377 392 10.1016/j.indmarman.2005.10.003
22. A preliminary examination of risk in the pharmaceutical supply chain (PSC) in the national health service (NHS), UK. Breen L, J Serv Sci Manag 2008 1 6
23. Supply chain risk management: literature review and future research. Vanany I, Zailani S, Pujawan N, Int J Inform Sys Supply Chain Manag 2009 2 16 33
24. PHP41 Risk management in iranian pharmaceutical companies to ensure accessibility and quality of medicines. Jaberidoost M, Abdollahiasl A, Farshchi A, Dinarvand R, Value Health 2012 15 616 A617
25. Global supply chain risk management strategies. Manuj I, Mentzer JT, Int J Phys Distr Log 2008 38 192 223 10.1108/09600030810866986
26. Assessing the problem of counterfeit medications in the United Kingdom. Jackson G, Patel S, Khan S, Int J Clin Pract 2012 66 241 250 10.1111/j.1742-1241.2011.02826.x 22070229
27. Counterfeit medicines. Tomić S, Filipović- Sučič A, Krivotvoreni lijekovi 2009 47 3 16
28. Technological roles in combating drug diversion and counterfeiting. Deus L, J Pharm Pract 2006 19 146 152 10.1177/0897190006292943 (Pubitemid 44401093)
29. Pharmaceutical supply chain security: a view from the pharmaceutical research and manufacturers of America. Goldhammer A, Lassman SM, J Pharm Prac 2006 19 239 243 10.1177/0897190006293514 (Pubitemid 44736385)
30. Cold chain management-an essential component of the global pharmaceutical supply chain. Bishara RH, Am Pharm Rev 2006 9 105 109
31. Quality assurance of raw materials: practical securing of high quality standards in production, quality control and distribution of drugs and excipients-part 2. Tawab M, Qualitätssicherung von ausgangsstoffen praxisnahe sicherstellung hoher qualitätsstandards in produktion, qualitätskontrolle und distribution von wirk-und hilfsstoffen 2010 72 418 426
32. Enterprise risk management in a pharmaceutical company. Rogachev AY, Risk Manage 2008 10 76 84 10.1057/palgrave.rm.8250037
33. From a literature review to a conceptual framework for sustainable supply chain management. Seuring S, Müller M, J Clean Prod 2008 16 1699 1710 10.1016/j.jclepro.2008.04.020
34. Perspectives in supply chain risk management. Tang CS, Int J Prod Econ 2006 103 451 488 10.1016/j.ijpe.2005.12.006 (Pubitemid 44038496)
35. A stochastic model for risk management in global supply chain networks. Goh M, Lim J, Meng F, Eur J Operatio Res 2007 182 164 173 10.1016/j.ejor.2006. 08.028 (Pubitemid 46561143)
36. Developing a suitable model for supplier selection based on supply chain risks: an empirical study from Iranian pharmaceutical companies. Mehralian G, Gatari AR, Morakabati M, Vatanpour H, Iranian J Pharm Res 2012 11 209 219
37. Analysing the external supply chain risk driver competitiveness: a risk mitigation framework and business continuity plan. Blos MF, Wee H-M, Yang J, J Bus Continuity Emerg Plan 2010 4 368 374
38. Quantification of Risk Mitigation in Ghanaian Pharmaceutical Industry Supply Chain. Enyinda CI, Mba CHN, Manu F, Adase SK, 10th Annual Conference Repositioning African Business and Development for the 21st Century IAABD: Sigue S, Sigue S, 2009 537 545
39. Enyinda C, Briggs C, Bachkar K, Managing risk in pharmaceutical global supply chain outsourcing: applying analytic hierarchy process model In ASBBS Annual Conference: LasVegas 2009
40. Evaluation of different types of risks in pharmaceutical supply-chain. Jnandev Kamath K, Kamath K, Azaruddin M, Subrahmanyam E, Shabharaya A, Am J Pharm Tech Res 2012 2 280 287
41. Risk-identification and strategic foresight based on history, management and complex systems perspectives-the example of the bio-pharmaceutical industry. Reschke CH, DRUID Summer Conference: Opening Up Innovation: Strategy, Organization and Technology BRUID: Imperial College London Business School 2010 16 18